Gallagher Fiduciary Advisors, LLC Agios Pharmaceuticals, Inc. Transaction History
Gallagher Fiduciary Advisors, LLC
- $3.01 Billion
- Q1 2025
A detailed history of Gallagher Fiduciary Advisors, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Gallagher Fiduciary Advisors, LLC holds 12,830 shares of AGIO stock, worth $475,479. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,830
Previous 11,110
15.48%
Holding current value
$475,479
Previous $365,000
2.74%
% of portfolio
0.01%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding AGIO
# of Institutions
237Shares Held
60MCall Options Held
323KPut Options Held
367K-
Farallon Capital Management LLC San Francisco, CA5.7MShares$211 Million0.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$208 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$180 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$130 Million2.39% of portfolio
-
State Street Corp Boston, MA2.45MShares$90.8 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.03B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...